Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users. Breast Cancer Res Treat. 2009 Nov; 118(1):125-30.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Alleles
Antineoplastic Agents, Hormonal
Biotransformation
Breast Neoplasms
Cohort Studies
Cytochrome P-450 CYP2D6
Female
Genotype
Humans
Middle Aged
Netherlands
Polymorphism, Single Nucleotide
Prodrugs
Proportional Hazards Models
Survival Analysis
Tamoxifen
authors with profiles
Albert Hofman, Ph.D., M.D.